Literature DB >> 22067045

Naturally occurring structural isomers in serum IgA1 o-glycosylation.

Kazuo Takahashi1, Archer D Smith, Knud Poulsen, Mogens Kilian, Bruce A Julian, Jiri Mestecky, Jan Novak, Matthew B Renfrow.   

Abstract

IgA is the most abundantly produced antibody and plays an important role in the mucosal immune system. Human IgA is represented by two isotypes, IgA1 and IgA2. The major structural difference between these two subclasses is the presence of nine potential sites of O-glycosylation in the hinge region between the first and second constant region domains of the heavy chain. Thr(225), Thr(228), Ser(230), Ser(232) and Thr(236) have been identified as the predominant sites of O-glycan attachment. The range and distribution of O-glycan chains at each site within the context of adjacent sites in this clustered region create a complex heterogeneity of surface epitopes that is incompletely defined. We previously described the analysis of IgA1 O-glycan heterogeneity by use of high resolution LC-MS and electron capture dissociation tandem MS to unambiguously localize all amino acid attachment sites in IgA1 (Ale) myeloma protein. Here, we report the identification and elucidation of IgA1 O-glycopeptide structural isomers that occur based on amino acid position of the attached glycans (positional isomers) and the structure of the O-glycan chains at individual sites (glycan isomers). These isomers are present in a model IgA1 (Mce1) myeloma protein and occur naturally in normal human serum IgA1. Variable O-glycan chains attached to Ser(230), Thr(233) or Thr(236) produce the predominant positional isomers, including O-glycans composed of a single GalNAc residue. These findings represent the first definitive identification of structural isomeric IgA1 O-glycoforms, define the single-site heterogeneity for all O-glycan sites in a single sample, and have implications for defining epitopes based on clustered O-glycan variability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22067045      PMCID: PMC3844682          DOI: 10.1021/pr200608q

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  68 in total

1.  Analysis of the microheterogeneity of the IgA1 hinge glycopeptide having multiple O-linked oligosaccharides by capillary electrophoresis.

Authors:  H Iwase; A Tanaka; Y Hiki; T Kokubo; T Sano; I Ishii-Karakasa; K Hisatani; Y Kobayashi; K Hotta
Journal:  Anal Biochem       Date:  2001-01-01       Impact factor: 3.365

2.  Label-free quantitation: a new glycoproteomics approach.

Authors:  Kathryn R Rebecchi; Jamie L Wenke; Eden P Go; Heather Desaire
Journal:  J Am Soc Mass Spectrom       Date:  2009-03-09       Impact factor: 3.109

3.  Structural elucidation of O-linked glycopeptides by high energy collision-induced dissociation.

Authors:  K F Medzihradszkyaff; B L Gillece-Castroaff; R R Townsendaff; A L Burlingameaff; M R Hardyaff
Journal:  J Am Soc Mass Spectrom       Date:  1996-04       Impact factor: 3.109

Review 4.  The impact of glycosylation on the biological function and structure of human immunoglobulins.

Authors:  James N Arnold; Mark R Wormald; Robert B Sim; Pauline M Rudd; Raymond A Dwek
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

5.  Structure determination of O-linked glycopeptides by tandem mass spectrometry.

Authors:  K F Medzihradszky; B L Gillece-Castro; C A Settineri; R R Townsend; F R Masiarz; A L Burlingame
Journal:  Biomed Environ Mass Spectrom       Date:  1990-12-05

6.  Elucidation of O-glycosylation structures of the beta-amyloid precursor protein by liquid chromatography-mass spectrometry using electron transfer dissociation and collision induced dissociation.

Authors:  Irina Perdivara; Robert Petrovich; Bernadette Allinquant; Bernadette Alliquant; Leesa J Deterding; Kenneth B Tomer; Michael Przybylski
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

7.  Analysis of glycoform of O-glycan from human myeloma immunoglobulin A1 by gas-phase hydrazinolysis following pyridylamination of oligosaccharides.

Authors:  H Iwase; I Ishii-Karakasa; E Fujii; K Hotta; Y Hiki; Y Kobayashi
Journal:  Anal Biochem       Date:  1992-10       Impact factor: 3.365

8.  Effector mechanisms of recombinant IgA antibodies against epidermal growth factor receptor.

Authors:  Michael Dechant; Thomas Beyer; Tanja Schneider-Merck; Wencke Weisner; Matthias Peipp; Jan G J van de Winkel; Thomas Valerius
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

9.  Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing.

Authors:  Michael Dechant; Gestur Vidarsson; Bernhard Stockmeyer; Roland Repp; Martin J Glennie; Martin Gramatzki; Jan G J van De Winkel; Thomas Valerius
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

10.  Quantitation of saccharide compositions of O-glycans by mass spectrometry of glycopeptides and its application to rheumatoid arthritis.

Authors:  Yoshinao Wada; Michiko Tajiri; Shiro Ohshima
Journal:  J Proteome Res       Date:  2010-03-05       Impact factor: 4.466

View more
  38 in total

Review 1.  Biomarkers in IgA nephropathy: relationship to pathogenetic hits.

Authors:  Margaret Colleen Hastings; Zina Moldoveanu; Hitoshi Suzuki; Francois Berthoux; Bruce A Julian; John T Sanders; Matthew B Renfrow; Jan Novak; Robert J Wyatt
Journal:  Expert Opin Med Diagn       Date:  2013-11

Review 2.  Immunoglobulin A nephropathy: a pathophysiology view.

Authors:  Rafaela Cabral Gonçalves Fabiano; Sérgio Veloso Brant Pinheiro; Ana Cristina Simões E Silva
Journal:  Inflamm Res       Date:  2016-06-28       Impact factor: 4.575

Review 3.  High-sensitivity analytical approaches for the structural characterization of glycoproteins.

Authors:  William R Alley; Benjamin F Mann; Milos V Novotny
Journal:  Chem Rev       Date:  2013-03-27       Impact factor: 60.622

Review 4.  Mass spectrometry of glycans.

Authors:  Liang Han; Catherine E Costello
Journal:  Biochemistry (Mosc)       Date:  2013-07       Impact factor: 2.487

Review 5.  The genetics and immunobiology of IgA nephropathy.

Authors:  Krzysztof Kiryluk; Jan Novak
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

6.  Site-specific glycosylation of secretory immunoglobulin A from human colostrum.

Authors:  Jincui Huang; Andres Guerrero; Evan Parker; John S Strum; Jennifer T Smilowitz; J Bruce German; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2015-02-11       Impact factor: 4.466

Review 7.  Glycosylation of IgA1 and pathogenesis of IgA nephropathy.

Authors:  Jan Novak; Bruce A Julian; Jiri Mestecky; Matthew B Renfrow
Journal:  Semin Immunopathol       Date:  2012-03-21       Impact factor: 9.623

Review 8.  Analysis of Mammalian O-Glycopeptides-We Have Made a Good Start, but There is a Long Way to Go.

Authors:  Zsuzsanna Darula; Katalin F Medzihradszky
Journal:  Mol Cell Proteomics       Date:  2017-11-21       Impact factor: 5.911

9.  Update on immunoglobulin A nephropathy, Part I: Pathophysiology.

Authors:  Maurizio Salvadori; Giuseppina Rosso
Journal:  World J Nephrol       Date:  2015-09-06

10.  Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy.

Authors:  Ying-Xin Xie; Li-Yu He; Xian Chen; Xiao-Fei Peng; Mu-Yao Ye; Yu-Jing Zhao; Wen-Zhe Yan; Chan Liu; Jing Shao; You-Ming Peng
Journal:  Int Urol Nephrol       Date:  2016-07-27       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.